Latest news

11 months ago

DemeRx Welcomes E. Matthew “Whiz” Buckley to Advisory Board

1 year ago

Addressing the addiction and mental health crises in the United States

2 years ago

Ibogaine and Noribogaine: Mechanisms and Therapeutic Potential as Addiction Medicines

2 years ago

Exploring the Future of VR and Digital Therapeutics

2 years ago

The Unparalleled Power of Ibogaine in Addiction Recovery With Tom Feegel, CEO of Beond

2 years ago

Breaking the Cycle of Addiction with Ibogaine

2 years ago

Ibogaine Receives Serious Media Attention

2 years ago

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

2 years ago

Psychedelics Today Ep. 448: Deborah C. Mash, Ph.D. – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy

2 years ago

Opium Addiction Market expected to rise – BioCorRx Inc, Delpor Inc, DemeRx Inc, Alar Pharmaceuticals, expected to drive market